In 2016, it's estimated that about half a million people in the U.S
In rats and mice, the effects on tendon and muscle healing have been consistent enough to get sports medicines attention
By stimulating the bodys own healing processes, they address the connective tissue weaknesses at the heart of EDSs most debilitating symptoms
Choi HK, Willett W, Curhan G
BPC-157 + TB-500 Multi-Compound Research Formulation
[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability